PRLog - March 7, 2011 - NEW YORK -- The American Conference Institute, organizers of the 6th Annual In-House Counsel Forum on Pharmaceutical Antitrust taking place May 10-11, 2011 at the Millennium UN Plaza Hotel in New York, today announced key highlights from this year’s program agenda.
Participation by Key FTC Officials
Attendees at this year’s conference will hear directly from an unprecedented group of key government officials directly involved in pharmaceutical antitrust enforcement. Participating in the event will be:
Commissioner J. Thomas Rosch
Michael B. Kades, Attorney Advisor to Chairman Jon Leibowitz
Tara Isa Koslov, Deputy Director, Office of Policy Planning
R ichard Feinstein, Director, Bureau of Competition:
Michael Moiseyev, Assistant Director, Mergers 1 Division
Christine White, Attorney, Healthcare Division
Focus on Global Antitrust Enforcement
Conduct by overseas regulators is taking on increasing importance as pharma companies look globally for business opportunities. This year’s forum will look at interaction between agencies around the world and analyze what regions present unique enforcement challenges. Valuable inside insights will be provided by antitrust specialists and officials from the EU and Brazil.
Demystifying FTC Processes
With the participation of many current and former senior FTC officials, considerable guidance will be provided that will illuminate how the Commission operates, and provide insights on effective practices for responding to an investigation.
Patent Settlement Considerations
In light of the recent renewed debate over patent settlements in the industry, it is important to be up-to-date on the most recent positions taken by the FTC and the courts. Detailed guidance will be provided at this year’s Forum that will make you able to structure a settlement that aligns with the Commission’s concerns, and survive close scrutiny.
Program Director Alan Forrest remarked, “This program is the culmination of detailed discussion with senior individuals at top law firms, government agencies, and pharmaceutical companies both in the U.S. and abroad. Attendees will have a rare opportunity to have their complex questions answered by the industry’s most expert regulators and practitioners.”
Full information on the forum can be found at www.acirxantitrust.com
# # #
A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.
Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.
Headquartered in New York and led by Benjamin J. Greenzweig, Managing Director, American Conference Institute has grown to produce more than 220 events each year, attended by thousands of senior delegates from across the country.